Subtopic Deep Dive

Insulin Resistance and AMPK Dysregulation
Research Guide

What is Insulin Resistance and AMPK Dysregulation?

Insulin Resistance and AMPK Dysregulation refers to impaired AMPK activity that disrupts insulin signaling, promoting metabolic dysfunction in diabetes and cancer.

AMPK senses cellular energy status and activates catabolic pathways, but its dysregulation in insulin-resistant states leads to ectopic lipid accumulation and inflammation (Jeon, 2016; 1061 citations). Studies link JNK-mediated serine phosphorylation of IRS-1 to TNFα-induced insulin resistance (Aguirre et al., 2000; 1456 citations). Over 10 key papers from 2000-2019 explore these pathways in metabolic tissues.

Curated Papers

Key Challenges

Why It Matters

Impaired AMPK exacerbates insulin resistance via lipid overload in liver and muscle, driving type 2 diabetes progression (Samuel and Shulman, 2016; 1328 citations). Dysregulated insulin signaling in adipose tissue links obesity to cancer risk through endocrine dysregulation (Coelho et al., 2013; 1054 citations; Vigneri et al., 2009; 996 citations). These insights guide therapies targeting AMPK activation for precision diabetes management and cancer prevention (Roden and Shulman, 2019; 1057 citations).

Key Research Challenges

Signaling Pathway Crosstalk

TNFα activates JNK to phosphorylate IRS-1 at Ser307, inhibiting insulin action, but exact kinase interactions remain unclear (Aguirre et al., 2000). AMPK opposes this by promoting glucose uptake, yet chronic energy surplus overrides it (Samuel and Shulman, 2016). Tissue-specific differences complicate modeling.

Tissue-Specific Dysregulation

Ectopic lipids impair insulin signaling differently in liver versus muscle, with AMPK suppression varying by isoform (Jeon, 2016). Adipose IR-A/IR-B hybrids alter sensitivity in obesity (Belfiore et al., 2009). Validating organ-specific roles requires advanced models.

Inflammation-Oxidative Link

Oxidative stress from AMPK loss amplifies inflammation, worsening resistance, but causal mediators are debated (DeFronzo et al., 2015). Cancer-diabetes overlap involves shared pathways like IGF-IR hybrids (Vigneri et al., 2009). Quantifying contributions challenges epidemiology.

Essential Papers

Insulin signalling and the regulation of glucose and lipid metabolism

Alan R. Saltiel, C. Ronald Kahn · 2001 · Nature · 5.2K citations

Type 2 diabetes mellitus

Ralph A. DeFronzo, Ele Ferrannini, Leif Groop et al. · 2015 · Nature Reviews Disease Primers · 2.4K citations

The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307

Vincent Aguirre, Tohru Uchida, Lynne Yenush et al. · 2000 · Journal of Biological Chemistry · 1.5K citations

Tumor necrosis factor alpha (TNFalpha) inhibits insulin action, in part, through serine phosphorylation of IRS proteins; however, the phosphorylation sites that mediate the inhibition are unknown. ...

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

Varman T. Samuel, Gerald I. Shulman · 2016 · Journal of Clinical Investigation · 1.3K citations

Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal...

The SLC2 (GLUT) family of membrane transporters

Mike Mueckler, Bernard Thorens · 2013 · Molecular Aspects of Medicine · 1.3K citations

Regulation and function of AMPK in physiology and diseases

Sang‐Min Jeon · 2016 · Experimental & Molecular Medicine · 1.1K citations

5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) is an evolutionarily conserved serine/threonine kinase that was originally identified as the key player in maintaining cellular ener...

The integrative biology of type 2 diabetes

Michael Roden, Gerald I. Shulman · 2019 · Nature · 1.1K citations

Reading Guide

Foundational Papers

Start with Saltiel and Kahn (2001; 5183 citations) for core insulin signaling, then Aguirre et al. (2000; 1456 citations) for JNK-IRS1 mechanisms, and Mueckler and Thorens (2013; 1262 citations) for GLUT transporters in resistance.

Recent Advances

Study Samuel and Shulman (2016; 1328 citations) for pathogenesis integration, Jeon (2016; 1061 citations) for AMPK regulation, and Roden and Shulman (2019; 1057 citations) for diabetes biology advances.

Core Methods

Core techniques: serine phosphorylation assays (Aguirre et al., 2000), nutrient flux tracing (Samuel and Shulman, 2016), AMPK activation screens (Jeon, 2016), and isoform expression profiling (Belfiore et al., 2009).

How PapersFlow Helps You Research Insulin Resistance and AMPK Dysregulation

Discover & Search

Research Agent uses citationGraph on Saltiel and Kahn (2001; 5183 citations) to map insulin signaling hubs, then findSimilarPapers reveals AMPK links like Jeon (2016). exaSearch queries 'AMPK dysregulation insulin resistance diabetes' to uncover 50+ related works from OpenAlex's 250M+ corpus.

Analyze & Verify

Analysis Agent runs readPaperContent on Aguirre et al. (2000) to extract JNK-IRS1 phosphorylation data, then verifyResponse with CoVe checks claims against DeFronzo et al. (2015). runPythonAnalysis with pandas plots citation trends and GRADE grades evidence strength for Samuel and Shulman (2016) pathway flux models.

Synthesize & Write

Synthesis Agent detects gaps in AMPK-GLUT4 integration from Mueckler and Thorens (2013), flags contradictions in isoform roles (Belfiore et al., 2009). Writing Agent applies latexEditText to draft reviews, latexSyncCitations for Belfiore et al., and latexCompile for publication-ready manuscripts; exportMermaid visualizes JNK-AMPK crosstalk diagrams.

Use Cases

"Extract lipid flux data from Samuel and Shulman 2016 and plot insulin resistance correlations"

Research Agent → searchPapers 'Samuel Shulman 2016' → Analysis Agent → readPaperContent → runPythonAnalysis (pandas/matplotlib for flux correlations) → matplotlib plot of ectopic lipid vs. HOMA-IR.

"Write LaTeX review on AMPK dysregulation in adipose tissue linking Coelho 2013 to Jeon 2016"

Synthesis Agent → gap detection on Coelho/Jeon → Writing Agent → latexEditText for draft → latexSyncCitations → latexCompile → PDF with integrated figures on endocrine dysregulation.

"Find GitHub repos analyzing JNK phosphorylation from Aguirre 2000"

Research Agent → searchPapers 'Aguirre 2000 JNK IRS1' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → curated list of simulation scripts for Ser307 models.

Automated Workflows

Deep Research workflow scans 50+ papers on 'insulin resistance AMPK', chains citationGraph → findSimilarPapers → structured report with GRADE-scored summaries (e.g., Saltiel-Kahn pathways). DeepScan applies 7-step CoVe to verify JNK-IRS1 claims from Aguirre et al. (2000) against Roden-Shulman (2019). Theorizer generates hypotheses on IR isoform-AMPK interactions from Belfiore et al. (2009).

Try Doxa for Insulin Resistance and AMPK Dysregulation Research

Frequently Asked Questions

What defines Insulin Resistance and AMPK Dysregulation?

It describes impaired AMPK energy sensing that blocks insulin signaling via IRS-1 serine phosphorylation and lipid accumulation (Aguirre et al., 2000; Samuel and Shulman, 2016).

What are key methods studied?

Methods include JNK inhibition assays for IRS-1 Ser307 (Aguirre et al., 2000), flux analysis for ectopic lipids (Samuel and Shulman, 2016), and AMPK activators in metabolic tissues (Jeon, 2016).

What are landmark papers?

Saltiel and Kahn (2001; 5183 citations) map insulin signaling; Aguirre et al. (2000; 1456 citations) detail JNK promotion of resistance; Jeon (2016; 1061 citations) reviews AMPK functions.

What open problems persist?

Unresolved issues include tissue-specific AMPK-IR isoform dynamics (Belfiore et al., 2009) and inflammation triggers overriding AMPK (DeFronzo et al., 2015).